Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, shock polarity, ...

ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...

Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among patients in the ED with acute atrial fibrillation, according to results of the RAFF-2 ...

Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent ...

In the open-label, phase IIIb ENSURE-AF trial, 2,199 patients undergoing electrical cardioversion of atrial fibrillation (AF) were randomly assigned to receive the oral direct factor Xa inhibitor ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Please provide your email address to receive an email when new articles are posted on . Citing safety concerns, the Cardiovascular and Renal Drug Advisory Committee of the FDA voted 2-11 against ...

The American College of Cardiology (ACC), American Heart Association, and the European Society of Cardiology define atrial fibrillation (AF) as a supraventricular tachyarrhythmia characterized by ...

Left atrial (LA) thrombus is not infrequently found in patients with atrial fibrillation (AF) or flutter who have been taking oral anticoagulation continuously for at least 3 weeks, a meta-analysis ...